Published in Clin Biochem on October 01, 1986
Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut (1992) 1.42
Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis. Gut (1993) 1.00
Colitis and colonic mucosal barrier dysfunction. Gut (1995) 0.96
Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut (1995) 0.89
Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation. Gut (1994) 0.86
Homeostasis of the Gut Barrier and Potential Biomarkers. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Secretory immunoglobulins. Adv Immunol (1968) 7.00
Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol (1979) 5.55
COMPLEMENT ACTIVITY IN PNEUMONIA. J Clin Invest (1942) 5.03
The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function. Cell (1990) 4.87
Mucosal immunology. Immunology (1980) 3.84
The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues. J Exp Med (1969) 3.08
PLASMA VOLUME AND "EXTRAVASCULAR THIOCYANATE SPACE" IN PNEUMOCOCCUS PNEUMONIA. J Clin Invest (1945) 2.83
NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci U S A (1990) 2.75
Cytotoxic activities of gut mucosal lymphoid cells in guinea pigs. J Immunol (1978) 2.70
Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J Immunol (1982) 2.66
Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer's patch and bronchial lymphocytes. J Immunol (1975) 2.57
Evidence-based rationing: Dutch pragmatism or government insensitivity? CMAJ (1998) 2.47
Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil (2010) 2.47
Isolation and characteristics of gut mucosal lymphocytes. Lab Invest (1974) 2.29
Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol (1984) 2.29
Bronchial lymphoid tissue. I. Morphologic characteristics. Lab Invest (1973) 2.17
Serum ferritin concentration and bone marrow iron stores: a prospective study. Can Med Assoc J (1978) 2.14
Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12
Peyer's patches: lack of specific antibody-containing cells after oral and parenteral immunization. J Immunol (1971) 1.99
Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol (1973) 1.96
Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci U S A (1987) 1.94
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol (1985) 1.85
Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol (1980) 1.79
Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol (1982) 1.77
Secretory gamma-A in normal urine. J Clin Invest (1968) 1.74
Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy (2010) 1.73
Morphologic and functional characteristics of human intestinal lymphoid cells isolated by a mechanical technique. Gastroenterology (1979) 1.73
The binding of salicylate to human serum. Biochem Pharmacol (1968) 1.68
Antinuclear factors in synovia. Possible participants in the rheumatoid inclusion body. JAMA (1966) 1.67
Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae. J Immunol (1972) 1.67
Studies on human intestinal immunoglobulin A. Gastroenterology (1971) 1.62
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
Increased erythromycin resistance in clinical Campylobacter in Northern Ireland--an update. J Antimicrob Chemother (2005) 1.60
Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Gastroenterology (1982) 1.59
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Human lung fibroblast-derived granulocyte-macrophage colony stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol (1989) 1.58
Lack of opsonization potential of 11S human secretory A. Proc Soc Exp Biol Med (1973) 1.56
Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism fingerprinting and artificial neural networks. Microbiology (1998) 1.54
Murine intestinal intraepithelial lymphocytes I. Relationship of a novel Thy-1-,Lyt-1-,Lyt-2+, granulated subpopulation to natural killer cells and mast cells. Eur J Immunol (1985) 1.49
Pain following colonoscopy: elimination with carbon dioxide. Gastrointest Endosc (1992) 1.48
A radioimmunoassay for serum ferritin. Clin Chem (1977) 1.48
Mast cell heterogeneity: derivation and function, with emphasis on the intestine. J Allergy Clin Immunol (1982) 1.46
Cyclic AMP signaling and gene regulation. Annu Rev Nutr (1998) 1.46
Intestinal mucosal mast cells from rats infected with Nippostrongylus brasiliensis contain protease-resistant chondroitin sulfate di-B proteoglycans. J Immunol (1986) 1.45
Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis. Arthritis Rheum (1967) 1.43
A common mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp Med Biol (1978) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. Ann Rheum Dis (1976) 1.42
Manubriosternal joint subluxation in rheumatoid arthritis. J Rheumatol (1983) 1.41
Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks. FEMS Microbiol Lett (1996) 1.41
Adverse effects of NSAIDs. Can Med Assoc J (1985) 1.39
Bronchial lymphoid tissue. II. Functional characterisitics. Lab Invest (1973) 1.36
Arteriovenous malformation of the stomach. Radiologic and endoscopic features. Am J Dig Dis (1978) 1.36
Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med (1982) 1.36
Some characteristics of human immunoconglutinin. J Immunol (1966) 1.36
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol (1984) 1.35
The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol (1987) 1.34
Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science (1989) 1.34
Lung defense mechanisms (first of two parts). N Engl J Med (1976) 1.32
Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A (1988) 1.28
Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol (1993) 1.27
Mast cell heterogeneity in man. I. Histologic studies of the intestine. Int Arch Allergy Appl Immunol (1985) 1.27
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut (2005) 1.27
Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood (1985) 1.27
The distribution of a rabbit thymic antigen and membrane immunoglobulins in lymphoid tissue, with special reference to mucosal lymphocytes. J Immunol (1975) 1.27
The structural basis for immunity in the respiratory tract. Int Rev Exp Pathol (1982) 1.26
What is the physiological function of mast cells? Exp Dermatol (2003) 1.26
Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet (1982) 1.25
Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am Rev Respir Dis (1984) 1.24
Lung defense mechanisms (second of two parts). N Engl J Med (1976) 1.23
Gut-associated lymphoid tissue in the chicken. I. Morphology, ontogeny, and some functional characteristics of Peyer's patches. J Immunol (1980) 1.23
Defining remission by cut off score on the MADRS: selecting the optimal value. J Affect Disord (2002) 1.23
Natural antibodies of human serum, saliva, and urine reactive with Escherichia coli. Proc Soc Exp Biol Med (1968) 1.22
Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunol (1987) 1.22
Antibody deficiency syndrome: a case with normal immunoglobulin levels. Clin Exp Immunol (1968) 1.22
Aspirin and gastrointestinal haemorrhage: a methodologic assessment. J Chronic Dis (1985) 1.21
A and non- A immune response after oral and parenteral immunization of the hamster. Cell Immunol (1971) 1.19
The proliferative response of bronchus-associated lymphoid tissue after local and systemic immunization. J Immunol (1974) 1.19
Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol (1987) 1.18
Transient polyarthritis associated with familial hyperbetalipoproteinaemia. Q J Med (1978) 1.18
Increased numbers of circulating basophil progenitors in atopic patients. J Allergy Clin Immunol (1985) 1.18
A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium. Lab Invest (1976) 1.17
Light-absorption studies on neutral flavin radicals. Eur J Biochem (1972) 1.15
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol (1996) 1.13
Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. J Immunol (1988) 1.13
Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population. J Immunol (1986) 1.13
Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol (1999) 1.12
Gut- and bronchus-associated lymphoid tissue. Am J Anat (1984) 1.11
Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med (1988) 1.10
Presence of intestinal intraepithelial lymphocytes in mice with severe combined immunodeficiency disease. Eur J Immunol (1990) 1.09
The covalently-bound flavin of hepatic monoamine oxidase. 1. Isolation and sequence of a flavin peptide and evidence for binding at the 8alpha position. Eur J Biochem (1971) 1.09
Distribution of serotypes and antibiotic resistance among pneumococci in Northern Ireland. J Infect (1988) 1.09
Intraepithelial leukocytes contain a unique subpopulation of NK-like cytotoxic cells active in the defense of gut epithelium to enteric murine coronavirus. J Immunol (1986) 1.09
Some thoughts on the biologic role of immunoglobulin A. Gastroenterology (1983) 1.08